Sr Manager, Business Development at Gilead Sciences

Sao Paulo, Sao Paulo, Brazil

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Minimum 10 years of experience in the pharmaceutical industry, ideally in Onco-Hematology, with a proven senior-level track record
Strong background in commercial leadership, portfolio negotiations, and strategic account management within the cell therapy segment
At least 3-5 years of direct experience in the Cell Therapy market
Demonstrated success in implementing innovative business models in Brazil, with strategic vision and planning capabilities in complex market environments
Availability for on-site work in São Paulo and frequent travel
Exceptional stakeholder management and relationship-building skills, both internally and with key clients in the Cell Therapy space
Fluent English preferred; advanced corporate-level writing and reading proficiency required
Self-motivated and able to work with a high level of autonomy and independence
Previous pharmaceutical hospital selling experience and relevant Cell Therapy (CART) environment knowledge
Proven expertise in interpersonal and relationship building skills along with strong influencing & negotiating skills
Ability to credibly discuss the science of the products with Key Opinion Leaders
Familiar with industry trends and remains current with competitor’s resources and practices
Ability to identify rising issues / solutions / opportunities and present / communicate arguments to management/marketing
In-depth understanding of the functions and inner workings of relevant establishments, determined by country
Good analytical skills

Responsibilities

Lead the commercial portfolio strategy, leveraging market and business intelligence to drive performance and growth
Optimize internal sales operations, including performance dashboards, credit and collections oversight, in close alignment with Finance
Define competitive positioning strategies and elevate customer experience across touchpoints
Co-lead strategic partnerships with key private accounts within the “Cluster-Ecosystem” framework, in collaboration with the Commercial and Market Access teams
Drive pre-launch and launch planning for new products, including Go-to-Market strategy, strategic alliances, and digital acceleration initiatives
Provide operational leadership for innovative business models such as OBS (risk-sharing) and IPM, ensuring alignment with global strategic objectives
Oversee development of promotional assets and support integrated marketing campaigns, with emphasis on digital strategy
Act as the primary interface with global marketing teams, ensuring brand consistency, innovation, and accountability for POA execution, budget management, and P&L oversight in partnership with Finance

Skills

Business Development

Commercial Strategy

Sales Operations

Market Intelligence

Performance Dashboards

Credit and Collections

Competitive Positioning

Customer Experience

Strategic Partnerships

Go-to-Market Strategy

Launch Planning

Risk-Sharing Models

Digital Acceleration

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free